These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 30903876)

  • 21. Antiphosphatidylserine/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome.
    Ząbczyk M; Celińska-Löwenhoff M; Plens K; Iwaniec T; Musiał J; Undas A
    J Thromb Haemost; 2019 Oct; 17(10):1746-1755. PubMed ID: 31220407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid Syndrome.
    Radin M; Foddai SG; Cecchi I; Rubini E; Schreiber K; Roccatello D; Bertolaccini ML; Sciascia S
    Thromb Haemost; 2020 Apr; 120(4):592-598. PubMed ID: 32185783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome].
    Ieko M; Nakabayashi T; Tarumi T; Yoshida M; Naito S; Atsumi T; Koike T
    Rinsho Byori; 2006 Mar; 54(3):256-62. PubMed ID: 16637574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review.
    Sciascia S; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML
    Thromb Haemost; 2014 Feb; 111(2):354-64. PubMed ID: 24172938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?
    Bardin N; Alessi MC; Dignat-George F; Vague IJ; Sampol J; Harlé JR; Sanmarco M
    Immunobiology; 2007; 212(7):557-65. PubMed ID: 17678713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and associations of anti-phosphatidylserine/prothrombin antibodies with clinical phenotypes in patients with primary antiphospholipid syndrome: aPS/PT antibodies in primary antiphospholipid syndrome.
    Núñez-Álvarez CA; Hernández-Molina G; Bermúdez-Bermejo P; Zamora-Legoff V; Hernández-Ramírez DF; Olivares-Martínez E; Cabral AR
    Thromb Res; 2019 Feb; 174():141-147. PubMed ID: 30612005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study.
    Nascimento IS; Radin M; Gândara APR; Sciascia S; de Andrade DCO
    Lupus; 2020 Jun; 29(7):676-685. PubMed ID: 32279584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia.
    Canti V; Del Rosso S; Tonello M; Lucianò R; Hoxha A; Coletto LA; Vaglio Tessitore I; Rosa S; Manfredi AA; Castiglioni MT; Ruffatti A; Rovere-Querini P
    J Rheumatol; 2018 Aug; 45(9):1263-1272. PubMed ID: 30008452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome].
    Reshetnyak TM; Cheldieva FA; Cherkasova MV; Lila AM; Nasonov EL
    Ter Arkh; 2022 Jun; 94(5):628-634. PubMed ID: 36286961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extra-criteria antiphospholipid antibodies in patients with small vessel brain lesions and clinical manifestations associated with antiphospholipid syndrome.
    Estévez MÁ; Lanio N; Molina Á; Jiménez-León MR; Picado MJ; Esteban E; Sánchez S; Pallarés L; Julià MR
    J Stroke Cerebrovasc Dis; 2023 May; 32(5):107034. PubMed ID: 36842350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events.
    Otomo K; Atsumi T; Amengual O; Fujieda Y; Kato M; Oku K; Horita T; Yasuda S; Koike T
    Arthritis Rheum; 2012 Feb; 64(2):504-12. PubMed ID: 21953404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added.
    Liu X; Zhu L; Liu H; Cai Q; Yun Z; Sun F; Jia Y; Guo J; Li C
    Front Immunol; 2022; 13():972012. PubMed ID: 36389827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Close link between antiphosphatidylserine/prothrombin antibodies, lupus anticoagulant, and activated protein C resistance in tetra antiphospholipid antibody-positive subjects.
    Pontara E; Bison E; Cattini MG; Tonello M; Denas G; Pengo V
    J Thromb Haemost; 2023 Nov; 21(11):3138-3144. PubMed ID: 37422199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
    Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
    Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant.
    Bertolaccini ML; Sciascia S; Murru V; Garcia-Fernandez C; Sanna G; Khamashta MA
    Thromb Haemost; 2013 Feb; 109(2):207-13. PubMed ID: 23254928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study.
    Sciascia S; Radin M; Cecchi I; Rubini E; Scotta A; Rolla R; Montaruli B; Pergolini P; Mengozzi G; Muccini E; Baldovino S; Ferro M; Vaccarino A; Mahler M; Menegatti E; Roccatello D
    Front Immunol; 2019; 10():376. PubMed ID: 30891041
    [No Abstract]   [Full Text] [Related]  

  • 37. Laboratory Testing for Non-criteria Antiphospholipid Antibodies: Anti-phosphatidylserine/Prothrombin Antibodies (aPS/PT).
    Devreese KMJ
    Methods Mol Biol; 2023; 2663():315-327. PubMed ID: 37204720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndrome.
    Vlagea A; Gil A; Cuesta MV; Arribas F; Diez J; Lavilla P; Pascual-Salcedo D
    Clin Appl Thromb Hemost; 2013 Jun; 19(3):289-96. PubMed ID: 22387581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays.
    Tsutsumi A; Hayashi T; Chino Y; Mamura M; Goto D; Matsumoto I; Ito S; Sumida T
    Mod Rheumatol; 2006; 16(3):158-64. PubMed ID: 16767554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies.
    Radin M; Barinotti A; Cecchi I; Foddai SG; Rubini E; Roccatello D; Menegatti E; Sciascia S
    J Clin Pathol; 2023 Dec; 76(12):839-846. PubMed ID: 36100400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.